Reliability and validity of the Turkish form of the eight-item morisky medication adherence scale in hypertensive patients

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 8, 2014, Pages 692-700

  Aşılar, Rabia HacıhasanoğLu ^a   Gözüm, Sebahat ^b   Çapık, Cantürk ^c   Morisky, Donald E ^d  

^a ERZINCAN UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c KAFKAS UNIVERSITY   (Turkey)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertension; Medication adherence; Scale; Validity

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BLOOD PRESSURE MEASUREMENT; BODY MASS; COMORBIDITY; CONSTRUCT VALIDITY; DIASTOLIC BLOOD PRESSURE; ECONOMIC ASPECT; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; TURKISH VERSION OF THE 8 ITEM MORISKY MEDICATION ADHERENCE SCALE; VALIDITY; MEDICATION COMPLIANCE; REPRODUCIBILITY; TURKEY; VALIDATION STUDY;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; MEDICATION ADHERENCE; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES; TURKEY;

EID: 84919789185     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.4982     Document Type: Article

References (27)

1. Laucka PV, Trotter JM. Medication management of hypertension. Topics in Geriatric Rehabilitation 2001; 17: 61-82. [CrossRef]
2. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9. [CrossRef]
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23. [CrossRef]
4. Altun B, Arıcı M, Nergizoğlu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005; 23: 1817-23. [CrossRef]
5. Arıcı M, Turgan C, Altun B, Sindel S, Erbay B, Derici U, et al. Hypertension incidence in Turkey (HinT): a population-based study. J Hypertens 2010; 28: 240-4. [CrossRef]
6. Düsing R. Overcoming barriers to effective blood pressure control in patients with hypertension. Curr Med Res Opin 2006; 22: 1545-52. [CrossRef]
7. Ogedegbe G. Barriers to optimal hypertension control. Hypertension. Curriculum Review. J Clin Hypertens 2008; 10: 644-6. [CrossRef]
8. Çakmak HA, Arslan E, Erdine S. (Unmet needs in hypertension). Turk Kardiyol Dern Ars 2009; 37: 1-4.
9. Clark LT, Afflu E. Antihypertensive therapy: Factors affecting medication compliance and blood pressure control. The American J Manager Care 1995; 1: 289-94.
10. Hill MN, Miller NH. Compliance to antihypertensive treatment. In Primary Hypertension, 3rd edn, Izzo JL & Black HR eds; Kazancı G translationed. Nobel Publication, İstanbul, 2004.p.390-3.
11. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19: 357-62. [CrossRef]
12. Coleman DJ. Medication compliance in the elderly. J Commun Nurs 2005; 19: 4-6.
13. Osterberg L, Blaschke T. Adherence to medication. NEJM 2005; 353: 487-97. [CrossRef]
14. Hacıhasanoğlu R. Responsibilities of the nurse in hypertension management. Fırat Sağlık Hizmetleri Dergisi 2009; 4: 153-64.
15. Gözüm S, Hacıhasanoğlu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. Eur J Cardiovasc Nurs 2009; 8: 129-36. [CrossRef]
16. Hacıhasanoğlu R, Gözüm S, Çapık C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anadolu Kardiyol Derg 2012; 12: 241-8.
17. Morisky D., Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348-54. [CrossRef]
18. Tavşancıl E. Tutumların ölçülmesi ve SPSS ile veri analizi. Ankara: Nobel Yayıncılık; 2002.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 289: 1206-52. [CrossRef]
20. WHO. Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser, Geneva. 2000; 894: 1-253.
21. Pett MA, Lackey NK, Sullivan JJ. Making sense of factor analysis the use of factor analysis for instrument development in health care research. California: Sage Publication; 2003.
22. Hacıhasanoğlu R, Gözüm S. The effect of patient education and home monitoring on medication compliance, hypertension management, healthy lifestyle behaviours and BMI in a primary health care setting. J Clin Nurs 2011; 20: 692-705. [CrossRef]
23. Baltaş Z. Sağlık psikolojisi. Istanbul: Remzi Kitapevi; 2004.
24. Türkiye İstatistik Kurumu (TUİK). İllere göre gayri safi yurtiçi hasılası (GSYH). (Cited 2012 September 2): Available from: http://www.tuik.gov.tr/VeriTabanlari.do?vt_id=45&ust_id=16.
25. Kalkınma Bakanlığı. İllerin sosyo-ekonomik gelişmişlik sıralaması güncellendi. (cited 2012 September 2): Available from: http://www.dpt.gov.tr/DocObjects/view/14197/BASIN_A%C3%87IKLAMASI-sege_2011-v6.pdf.
26. Hacıhasanoğlu R. Treatment compliance affecting factors in hypertension. TAF Preventive Medicine Bulletin 2009; 8: 167-72.
27. Özdemir L. Yaşlılıkta ilaç uyumu ve ilaç uyumunu etkileyen faktörler. Akademik Geriatri Dergisi 2012; 4: 18.